Synthon B.V.

Synthon B.V. is an international pharmaceutical company and complex generic medicine manufacturer headquartered in Nijmegen, Netherlands. Founded in 1991, the company specializes in the development, active pharmaceutical ingredient manufacturing, and global commercialization of high-quality small-molecule generics and hybrid pharmaceuticals. Operating as a science-driven leader, Synthon serves B2B partners and direct-to-market pharmaceutical channels across global markets including Spain, the Czech Republic, Chile, Mexico, and Argentina. The company's product portfolio features complex generic pharmaceuticals across critical therapeutic areas such as oncology, including formulations like Abiraterone, Anagrelide, and Anastrozole. As a vertically integrated supplier, Synthon maintains advanced research and development centers alongside state-of-the-art API and finished dosage drug product manufacturing facilities. The organization delivers capabilities ranging from active pharmaceutical ingredient synthesis to full-scale drug formulation and regulatory compliance. Synthon collaborates with international pharmaceutical distributors, commercial partners, and healthcare providers to expand global access to safe and affordable medicines.